Probiotic Interventions in Candidiasis Management

Candidiasis, caused predominantly by Candida albicans, represents a significant burden across mucosal and systemic sites, with rising incidence of antifungal resistance and recurrent infections. Probiotic interventions harness beneficial microorganisms, chiefly Lactobacillus species and selected yeasts, to restore or maintain microbial balance at vulnerable niches such as the vagina, oral cavity and gastrointestinal tract. These live biotherapeutic agents act through multiple mechanisms: they acidify the local environment via lactic acid production, secrete antifungal compounds, compete for adhesion sites, disrupt Candida biofilms and modulate host defences. Recent advances have moved beyond monostrain formulations to multispecies consortia and synbiotic combinations pairing probiotics with prebiotic substrates. Such approaches hold promise for preventing recurrence, reducing drug exposure and broadening access to affordable, non-toxic therapies worldwide.

Research from Nature Portfolio

In a 2024 study, combinations of Lactobacillaceae isolates and the probiotic yeast Saccharomyces cerevisiae CNCM I-3856 were shown to exert multifactorial inhibition of C. albicans in vitro. Selected lactobacilli inhibited planktonic growth, suppressed hyphal development by up to 78 %, and co-aggregated with yeast cells; synergy with S. cerevisiae enhanced aggregation without antagonism between beneficial strains. These findings suggest that defined probiotic consortia may achieve broader anticandidal activity than single strains alone. An earlier investigation demonstrated that vaginal isolates of Lactobacillus crispatus and L. fermentum produce a heat- and protease-resistant compound that inhibits C. albicans proliferation and hyphal induction, even after neutralisation of acidity. In a murine model of vulvovaginal candidiasis, combined supernatants from these species effectively limited fungal colonisation, highlighting the translational potential of probiotic-derived metabolites for in vivo application.

Probiotic Interventions in Candidiasis Management publication trend

The graph below shows the total number of articles in probiotic interventions in candidiasis management across all publications each year (not limited to Nature Index journals).

Technical terms

Probiotic: Live microbe that, when administered in adequate amounts, confers a health benefit on the host.

Biofilm: A structured community of microorganisms adherent to surfaces and embedded in a self-produced extracellular matrix, often resistant to conventional therapies.

Hyphae: Filamentous fungal structures; the switch from yeast to hyphal form is a key virulence trait of Candida species.

Synbiotic: A combined formulation of probiotics and prebiotic substrates designed to support the survival and activity of beneficial microbes.

Cell-free culture supernatant: The liquid fraction obtained after removal of microbial cells, containing secreted metabolites and bioactive molecules.

References

1. Multifactorial inhibition of Candida albicans by combinations of lactobacilli and probiotic Saccharomyces cerevisiae CNCM I-3856. Scientific Reports (2024).
2. Synergistic Inhibition of Synbiotic Cultures among Lactobacilli and Plant Extracts against Vaginal Discharge Causing Candida albicans. Nutrients (2024).
3. Inhibitory effects of vaginal Lactobacilli on Candida albicans growth, hyphal formation, biofilm development, and epithelial cell adhesion. Frontiers in Cellular and Infection Microbiology (2023).
4. Protective Properties of S-layer Protein 2 from Lactobacillus crispatus 2029 against Candida albicans Infections. Biomolecules (2023).